Y Mabs Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Y Mabs Therapeutics (YMAB) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Y Mabs Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Y Mabs Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Y Mabs Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $5.9M | 366k | 16.26 |
| 2023-12-31 | $2.7M | 398k | 6.82 |
| 2023-09-30 | $2.1M | 389k | 5.45 |
| 2023-06-30 | $2.7M | 403k | 6.79 |
| 2023-03-31 | $956k | 191k | 5.01 |
| 2022-12-31 | $1.5M | 317k | 4.88 |
| 2022-06-30 | $2.3M | 152k | 15.13 |
| 2022-03-31 | $1.5M | 126k | 11.87 |
| 2021-12-31 | $3.5M | 217k | 16.21 |
| 2021-09-30 | $23M | 813k | 28.54 |
| 2021-03-31 | $25M | 818k | 30.24 |
| 2020-12-31 | $43M | 861k | 49.51 |
| 2020-09-30 | $28M | 726k | 38.39 |
| 2020-06-30 | $25M | 580k | 43.18 |
| 2019-12-31 | $18M | 577k | 31.25 |
| 2019-09-30 | $6.8M | 263k | 26.08 |
| 2019-06-30 | $5.2M | 226k | 22.87 |
| 2019-03-31 | $5.9M | 225k | 26.21 |
| 2018-12-31 | $4.8M | 238k | 20.34 |
| 2018-09-30 | $8.3M | 311k | 26.56 |